Insider · CIK 0001597583
L Daniel Browne
Files at: RVNC. On EDGAR ↗
Reported trades — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 19, 2019 SForm 4 → | Feb 20, 9:31 pm EST | Revance Therapeutics, Inc.RVNC | 5,446 | $17.68 | $96,285 | 168,943 | −3.12% | plan? |
| Feb 15, 2019 FForm 4 → | Feb 20, 9:31 pm EST | Revance Therapeutics, Inc.RVNC | 3,154 | $17.69 | $55,794 | 174,389 | — | plan? |
| Jan 24, 2019 AForm 4 → | Jan 25, 9:02 pm EST | Revance Therapeutics, Inc.RVNC | 35,000 | — | — | 177,543 | — | plan? |
| Jun 29, 2018 JForm 4 → | Jul 3, 8:17 pm EDT | Revance Therapeutics, Inc.RVNC | 668 | $23.33 | $15,586 | 142,543 | — | plan? |
| Mar 15, 2018 FMForm 4 → | Mar 16, 8:03 pm EDT | Revance Therapeutics, Inc.RVNC | 22,881 | $6.21 | $142,184 | 147,327 | — | plan? |
| Mar 15, 2018 SForm 4 → | Mar 16, 8:03 pm EDT | Revance Therapeutics, Inc.RVNC | 6,452 | $31.64 | $204,148 | 141,875 | −4.35% | plan? |
| Mar 7, 2018 SForm 4 → | Mar 9, 8:36 pm EST | Revance Therapeutics, Inc.RVNC | 27,283 | $31.43 | $857,505 | 131,208 | −17.2% | plan? |
| Feb 15, 2018 FForm 4 → | Feb 16, 7:42 pm EST | Revance Therapeutics, Inc.RVNC | 3,074 | $31.75 | $97,600 | 158,491 | — | plan? |
| Feb 8, 2018 AForm 4 → | Feb 9, 9:21 pm EST | Revance Therapeutics, Inc.RVNC | 28,250 | — | — | 161,565 | — | plan? |
| Dec 29, 2017 JForm 4 → | Jan 3, 2018, 8:13 pm EST | Revance Therapeutics, Inc.RVNC | 127 | $22.99 | $2,920 | 133,315 | — | plan? |
| Nov 22, 2017 SForm 4 → | Nov 24, 4:06 pm EST | Revance Therapeutics, Inc.RVNC | 7,600 | $24.94 | $189,570 | 133,188 | −5.40% | plan? |
| Oct 18, 2017 SForm 4 → | Oct 20, 8:10 pm EDT | Revance Therapeutics, Inc.RVNC | 7,662 | $26.16 | $200,405 | 140,788 | −5.16% | plan? |
| Sep 20, 2017 SForm 4 → | Sep 22, 8:08 pm EDT | Revance Therapeutics, Inc.RVNC | 7,600 | $23.58 | $179,185 | 148,450 | −4.87% | plan? |
| Aug 23, 2017 SForm 4 → | Aug 25, 7:41 pm EDT | Revance Therapeutics, Inc.RVNC | 22,800 | $22.76 | $519,031 | 156,050 | −12.7% | plan? |
| Aug 23, 2017 MForm 4 → | Aug 25, 7:41 pm EDT | Revance Therapeutics, Inc.RVNC | 331 | $2.55 | $844 | 178,850 | — | plan? |
| Jun 30, 2017 JForm 4 → | Jul 5, 9:29 pm EDT | Revance Therapeutics, Inc.RVNC | 1,000 | $18.32 | $18,318 | 178,519 | — | plan? |
| Jun 12, 2017 MForm 4 → | Jun 14, 8:11 pm EDT | Revance Therapeutics, Inc.RVNC | 8,300 | $2.55 | $21,165 | 177,519 | — | plan? |
| May 30, 2017 MForm 4 → | May 31, 9:38 pm EDT | Revance Therapeutics, Inc.RVNC | 5,000 | $2.55 | $12,750 | 169,219 | — | plan? |
| May 22, 2017 SForm 4 → | May 24, 9:13 pm EDT | Revance Therapeutics, Inc.RVNC | 32,000 | $20.29 | $649,250 | 164,219 | −16.3% | plan? |
| Mar 16, 2017 FForm 4 → | Mar 17, 7:23 pm EDT | Revance Therapeutics, Inc.RVNC | 3,171 | $19.20 | $60,885 | 196,219 | — | plan? |
| Feb 22, 2017 SForm 4 → | Feb 24, 9:04 pm EST | Revance Therapeutics, Inc.RVNC | 11,037 | $20.57 | $227,050 | 199,390 | −5.25% | plan? |
| Jan 26, 2017 AForm 4 → | Jan 30, 9:28 pm EST | Revance Therapeutics, Inc.RVNC | 25,800 | — | — | 210,427 | — | plan? |
| Jan 25, 2017 SForm 4 → | Jan 27, 8:04 pm EST | Revance Therapeutics, Inc.RVNC | 12,000 | $19.78 | $237,398 | 184,627 | −6.10% | plan? |
| Dec 30, 2016 JForm 4 → | Jan 3, 2017, 5:52 pm EST | Revance Therapeutics, Inc.RVNC | 1,000 | $11.58 | $11,577 | 196,627 | — | plan? |
| Dec 28, 2016 SForm 4 → | Dec 30, 6:38 pm EST | Revance Therapeutics, Inc.RVNC | 12,000 | $20.94 | $251,250 | 195,627 | −5.78% | plan? |
| Nov 25, 2016 SForm 4 → | Nov 25, 9:32 pm EST | Revance Therapeutics, Inc.RVNC | 12,000 | $17.92 | $215,005 | 207,627 | −5.46% | plan? |
| Oct 26, 2016 SForm 4 → | Oct 28, 9:29 pm EDT | Revance Therapeutics, Inc.RVNC | 12,000 | $14.85 | $178,199 | 219,627 | −5.18% | plan? |
| May 19, 2016 FForm 4 → | May 23, 9:28 pm EDT | Revance Therapeutics, Inc.RVNC | 12,050 | $17.11 | $206,176 | 231,627 | — | plan? |
| Feb 9, 2016 AForm 4 → | Feb 11, 8:15 pm EST | Revance Therapeutics, Inc.RVNC | 25,000 | — | — | 243,677 | — | plan? |
| Dec 30, 2015 JMForm 4 → | Jan 4, 2016, 9:10 pm EST | Revance Therapeutics, Inc.RVNC | 12,307 | $3.07 | $37,789 | 218,677 | — | plan? |
| Jun 30, 2015 JForm 4 → | Jul 2, 8:35 pm EDT | Revance Therapeutics, Inc.RVNC | 1,000 | $14.16 | $14,160 | 1,000 | — | plan? |
| May 19, 2015 FForm 4 → | May 21, 6:46 pm EDT | Revance Therapeutics, Inc.RVNC | 12,025 | $25.94 | $311,929 | 205,101 | — | plan? |
| Jan 28, 2015 AForm 4 → | Jan 30, 7:09 pm EST | Revance Therapeutics, Inc.RVNC | 43,500 | — | — | 217,126 | — | plan? |
Reported trades — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 24, 2019 AForm 4 → | Jan 25, 9:02 pm EST | Revance Therapeutics, Inc.RVNC | 200,000 | — | — | 200,000 | — | |
| Mar 16, 2018 MForm 4 → | Mar 16, 8:03 pm EDT | Revance Therapeutics, Inc.RVNC | 20,000 | — | — | 0 | — | |
| Feb 8, 2018 AForm 4 → | Feb 9, 9:21 pm EST | Revance Therapeutics, Inc.RVNC | 169,000 | — | — | 169,000 | — | |
| Aug 23, 2017 MForm 4 → | Aug 25, 7:41 pm EDT | Revance Therapeutics, Inc.RVNC | 331 | — | — | 10,990 | — | |
| Jun 12, 2017 MForm 4 → | Jun 14, 8:11 pm EDT | Revance Therapeutics, Inc.RVNC | 8,300 | — | — | 11,321 | — | |
| May 30, 2017 MForm 4 → | May 31, 9:38 pm EDT | Revance Therapeutics, Inc.RVNC | 5,000 | — | — | 19,621 | — | |
| Jan 26, 2017 AForm 4 → | Jan 30, 9:28 pm EST | Revance Therapeutics, Inc.RVNC | 155,000 | — | — | 155,000 | — | |
| Feb 9, 2016 AForm 4 → | Feb 11, 8:15 pm EST | Revance Therapeutics, Inc.RVNC | 175,000 | — | — | 175,000 | — | |
| Dec 30, 2015 MForm 4 → | Jan 4, 2016, 9:10 pm EST | Revance Therapeutics, Inc.RVNC | 12,045 | — | — | 24,621 | — | |
| Jan 28, 2015 AForm 4 → | Jan 30, 7:09 pm EST | Revance Therapeutics, Inc.RVNC | 246,500 | — | — | 246,500 | — |